Inventor · disambiguated record
Jing Ai
Also filed as: AI JING
11 granted patents·6 pending applications·3 citations·filing 2011–2020
78Inventor score
Files withSHANGHAI INST MATERIA MEDICA CAS8SHANGHAI FOCHON PHARMACEUTICAL CO LTD2SHANGHAI HAIHE PHARMACEUTICAL CO LTD2DUAN WENHU1HAIHE BIOPHARMA CO LTD1
Top patents by PatentIndex Score
17 records- 0173US9206166B2Certain protein kinase inhibitorsSHANGHAI FOCHON PHARMACEUTICAL CO LTD·Filed 2013·Granted Dec 8, 2015·2 cites·20 claims
- 0268US10683278B2Substituted quinolone derivatives, or pharmaceutically acceptable salts or stereoisomers thereof, and pharmaceutical compositions and use thereofUNIV JINAN·Filed 2016·Granted Jun 16, 2020·1 cites·11 claims
- 0348US12479850B2Compound having Axl and c-Met kinase inhibitory activity, preparation thereof and application thereofSHANGHAI INST MATERIA MEDICA CAS·Filed 2020·Granted Nov 25, 2025·0 cites·7 claims
- 0445US12497394B2Fused-cyclic pyrazolone formamide compound and preparation method therefor, pharmaceutical composition and use thereofSHANGHAI INST MATERIA MEDICA CAS·Filed 2019·Granted Dec 16, 2025·0 cites·12 claims
- 0545US10058566B2Sulfated polygulonic acid polysaccharide or pharmaceutical salt thereof, preparation method therefor and use thereofSHANGHAI INST MATERIA MEDICA CAS·Filed 2014·Granted Aug 28, 2018·0 cites·14 claims
- 0642US9567342B2Certain protein kinase inhibitorsSHANGHAI FOCHON PHARMACEUTICAL CO LTD·Filed 2015·Granted Feb 14, 2017·0 cites·20 claims
- 0741US11834432B2Substituted amino six-membered nitric heterocyclic ring compound and preparation and use thereofSHANGHAI INST MATERIA MEDICA CAS·Filed 2017·Granted Dec 5, 2023·0 cites·16 claims
- 0841US11655239B2Fused ring pyrimidine amino compound and preparation method, pharmaceutical composition, and use thereofSHANGHAI INSTITUTE OF MAT MEDICA CHINESE ACADEMY OF SCIENCES·Filed 2020·Granted May 23, 2023·0 cites·16 claims
- 0941US2021261539A1Compound having bet inhibitory activity and preparation method and use thereforSHANGHAI HAIHE PHARMACEUTICAL CO LTD·Filed 2019·Application pending·0 cites
- 1039US10988456B2O-aminoheteroaryl alkynyl-containing compound, preparation method therefor, and use thereofSHANGHAI INST MATERIA MEDICA CAS·Filed 2018·Granted Apr 27, 2021·0 cites·17 claims
- 1136US10710996B2Pyrido-azaheterecydic compound and preparation method and use thereofSHANGHAI INST MATERIA MEDICA CAS·Filed 2016·Granted Jul 14, 2020·0 cites·7 claims
- 1236US2013324542A1[1,2,4]triazolo[4,3-b][1,2,4]triazine compounds, preparation method and use thereofDUAN WENHU·Filed 2011·Application pending·0 cites
- 1335US10562900B2Indazole compounds as FGFR kinase inhibitor, preparation and use thereofSHANGHAI HAIHE PHARMACEUTICAL CO LTD·Filed 2015·Granted Feb 18, 2020·0 cites·15 claims
- 1435US2019367520A1New compound having fgfr inhibitory activity and preparation and application thereofSHANGHAI INST MATERIA MEDICA CAS·Filed 2017·Application pending·0 cites
- 1534US2019135818A15-membered heterocycle fused with [3,4-d] pyridazinone, and manufacturing method, pharmaceutical composition, and application thereofSHANGHAI INST MATERIA MEDICA CAS·Filed 2017·Application pending·0 cites
- 1633US2016145244A1Certain protein kinase inhibitorsWANG WEIBO·Filed 2015·Application pending·0 cites
- 1732US2021078972A1Quinoline or quinazoline compound and application thereofHAIHE BIOPHARMA CO LTD·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jing Ai files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →